Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiji Fang

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Molecular Biosciences|August 9, 2020
ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular CarcinomaWeiqian Chen, Minjiang Chen, Zhongwei Zhao, et al.
ACS Nano|March 11, 2024
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Gao-Feng Shu, et al.
Frontiers in Molecular Biosciences|September 17, 2021
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency AblationShiji Fang, Linqiang Lai, Jinyu Zhu, et al.
Cell Death & Disease|September 22, 2018
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistanceMin Xu, Shiji Fang, Jingjing Song, et al.
European Journal of Pharmacology|December 25, 2022
Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathwayShiji Fang, Liyun Zheng, Lin Shen, et al.
European Radiology|April 16, 2021
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACEChunli Kong, Zhongwei Zhao, Weiyue Chen, et al.
Asian Journal of Pharmaceutical Sciences|April 10, 2024
Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapyXiaoju Guo, Xiaoxiao Chen, Jiayi Ding, et al.
Frontiers in Immunology|November 26, 2020
Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental ColitisBufu Tang, Jinyu Zhu, Baohui Zhang, et al.
Asian Journal of Pharmaceutical Sciences|June 19, 2026
Mesoporous polydopamine nanoplatform enhances IL-2 immunotherapy for hepatocellular carcinoma via mild photothermal therapy and lactate regulationFengkai Qiu, Xiaoxiao Chen, Qianhui He, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 25, 2020
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathwayZhongwei Zhao, Jingjing Song, Bufu Tang, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Molecular Biosciences|August 9, 2020
ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular CarcinomaWeiqian Chen, Minjiang Chen, Zhongwei Zhao, et al.
ACS Nano|March 11, 2024
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Gao-Feng Shu, et al.
Frontiers in Molecular Biosciences|September 17, 2021
A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency AblationShiji Fang, Linqiang Lai, Jinyu Zhu, et al.
Cell Death & Disease|September 22, 2018
CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistanceMin Xu, Shiji Fang, Jingjing Song, et al.
European Journal of Pharmacology|December 25, 2022
Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathwayShiji Fang, Liyun Zheng, Lin Shen, et al.
European Radiology|April 16, 2021
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACEChunli Kong, Zhongwei Zhao, Weiyue Chen, et al.
Asian Journal of Pharmaceutical Sciences|April 10, 2024
Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapyXiaoju Guo, Xiaoxiao Chen, Jiayi Ding, et al.
Frontiers in Immunology|November 26, 2020
Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental ColitisBufu Tang, Jinyu Zhu, Baohui Zhang, et al.
Asian Journal of Pharmaceutical Sciences|June 19, 2026
Mesoporous polydopamine nanoplatform enhances IL-2 immunotherapy for hepatocellular carcinoma via mild photothermal therapy and lactate regulationFengkai Qiu, Xiaoxiao Chen, Qianhui He, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 25, 2020
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathwayZhongwei Zhao, Jingjing Song, Bufu Tang, et al.
Pageof 8